References
- NicolsWWO’RourkeMFMcDonald’s Blood Flow in Arteries: Theoretical Experimental and Clinical PrinciplesEdward ArnoldLondon199854113
- LaurentSCockcroftJBortelLBoutouyriePGiannattasioCDaniel HayozDEuropean network for non-invasive investigation of large arteries expert consensus document on arterial stiffness: methodological issues and clinical applicationsEur Heart J2006272588260517000623
- ProtogerouADPapaioannouTGLekakisJPBlacherJSafarMEThe effect of antihypertensive drugs on central blood pressure beyond peripheral blood pressure. Part I: (patho)-physiology, rationale and perspective on pulse pressure amplificationCurr Pharm Des20091526727119149617
- GreenwaldSEAgeing of the conduit arteriesJ Pathol200721115717217200940
- SafarMELevyBIStruijker-BoudierHCurrent perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseasesCirculation20031072864286912796414
- WilliamsBLacyPSThomSMCruickshankKStantonACollierDfor CAFE InvestigatorsAnglo-Scandinavian Cardiac Outcomes Trial InvestigatorsCAFE Steering Committee and Writing Committee. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) studyCirculation20061131213122516476843
- LaurentSBoutouyriePRecent advances in arterial stiffness and wave reflection in human hypertensionHypertension2007491202120617452508
- KellyRPMillasseauSCRitterJMChowienczykPJVasoactive drugs influence aortic augmentation index independently of pulse-wave velocity in healthy menHypertension2001371429143311408390
- O’RourkeMFManciaGArterial stiffnessJ Hypertens1999171410100086
- O’RourkeMFNicholsWWSafarMEBrachial and central arterial pressureHypertension200648e116717143
- McEnieryCMYasmin HallIRQasemAWilkinsonIBCockcroftJRNormal vascular aging: differential effects on wave reflection and aortic pulse wave velocity: the Anglo Cardiff Collaborative Trial (ACCT)J Am Coll Cardiol2005461753176016256881
- LaurentSKatsahianSFassotCAortic stiffness is an independent predictor of fatal stroke in essential hypertensionStroke2003341203120612677025
- BlacherJSafarMEGuerinAPPannierBMarchaisSJLondonGMAortic pulse wave velocity index and mortality in end-stage renal diseaseKidney Int2003631852186012675863
- GuerinAPBlacherJPannierBMarchaisSJSafarMELondonGMImpact of aortic stiffness attenuation on survival of patients in end-stage renal failureCirculation200110398799211181474
- LondonGMBrachial arterial pressure to assess cardiovascular structural damage: an overview and lessons from clinical trialsJ Nephrol200821233118264933
- StehouwerCDHenryRMFerreiraIArterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular diseaseDiabetologia20085152753918239908
- BlacherJAsmarRDjaneSLondonGMSafarMEAortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patientsHypertension1999331111111710334796
- ZiemanSJMelenovskyVKassDAMechanisms, pathophysiology, and therapy of arterial stiffnessArterioscler Thromb Vasc Biol20052593294315731494
- LuftFCAngiotensin, inflammation, hypertension, and cardiovascular diseaseCurr Hypertens Rep20013616711177710
- Guidelines Committee2003 European Society of Hypertension – European Society of Cardiology guidelines for the management of arterial hypertensionJ Hypertens2003211011105312777938
- WilliamsBPoulterNRBrownMJfor British Hypertension SocietyGuidelines for management of hypertension: report of the fourth Working Party of the British Hypertension Society, 2004-BHS IVJ Hum Hypertens20041813918514973512
- WilliamsBO’RourkeMfor Anglo-Scandinavian Cardiac Outcomes TrialThe Conduit Artery Functional Endpoint (CAFE) study in ASCOTJ Hum Hypertens200115Suppl 1S69S7311685915
- KarallieddeJSmithADeAngelisLValsartan improves arterial stiffness in type 2 diabetes independently of blood pressure loweringHypertension2008511617162318426991
- MatsuiYEguchiKO’RourkeMFDifferential effects between a calcium channel blocker and a diuretic when used in combination with angiotensin II receptor blocker on central aortic pressure in hypertensive patientsHypertension20095471672319667251
- AsmarRGLondonGMO’RourkeMESafarMEfor REASON Project Coordinators and InvestigatorsImprovement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patient: a comparison with atenololHypertension20013892292611641310
- GirerdXGiannattasioCMoulinCSafarMManciaGLaurentSRegression of radial artery wall hypertrophy and improvement of carotid artery compliance after long-term antihypertensive treatment in elderly patientsJ Am Coll Cardiol199831106410739562008
- BénétosALaflècheAAsmarRGautierSSafarASafarMEArterial stiffness, hydrochlorothiazide and converting enzyme inhibition in essential hypertensionJ Hum Hypertens19961077828867559
- MackenzieISMcEnieryCMDhakamZBrownMJCockcroftJRWilkinsonIBComparison of the effects of antihypertensive agents on central blood pressure and arterial stiffness in isolated systolic hypertensionHypertension20095440941319487582
- DhakamZMcEnieryCMYasmin CockcroftJRBrownMJWilkinsonIBAtenolol and eprosartan: differential effects on central blood pressure and aortic pulse wave velocityAm J Hypertens20061921421916448896
- BenetosALacolleyPSafarMEPrevention of aortic fibrosis by spironolactone in spontaneously hypertensive ratsArterioscler Thromb Vasc Biol199717115211569194767
- BlacherJAmahGGirerdXAssociation between increased plasma levels of aldosterone and decreased systemic arterial compliance in subjects with essential hypertensionAm J Hypertens199710132613349443767
- WhiteWBDuprezDSt HillaireREffects of the selective aldosterone blocker eplerenone versus the calcium antagonist amlodipine in systolic hypertensionHypertension2003411021102612682082
- MahmudAFeelyJReduction in arterial stiffness with angiotensin II antagonist is comparable with and additive to ACE inhibitionAm J Hypertens20021532132511991217
- MesserliFHThe sudden demise of dual renin-angiotensin system blockade or the soft science of the surrogate end pointJ Am Coll Cardiol20095346847019195602
- MahmudAFeelyJBeta-blockers reduce aortic stiffness in hypertension but nebivolol, not atenolol, reduces wave reflectionAm J Hypertens20082166366718437130
- DhakamZYasmin McEnieryCMBurtonTBrownMJWilkinsonIBA comparison of atenolol and nebivolol in isolated systolic hypertensionJ Hypertens20082635135618192850
- KomaiNOhishiMMoriguchiAYanagitaniYJinnoTMatsumotoKLow-dose doxazosin improved aortic stiffness and endothelial dysfunction as measured by noninvasive evaluationHypertens Res20022551011924726
- MahmudAFeelyJDoxazosin reduces augmentation index but not pulse wave velocity in essential hypertensionBr J Clin Pharmacol200661628
- FitchettDHSimkusGJBeaudryJPMarpoleDGReflected pressure waves in the ascending aorta: effect of glyceryl trinitrateCardiovasc Res1988224945003150945
- VuurmansTJBoerPKoomansHAEffects of endothelin-1 and endothelin-1 receptor blockade on cardiac output, aortic pressure, and pulse wave velocity in humansHypertension2003411253125812743011
- DhaunNMacintyreIMMelvilleVEffects of endothelin receptor antagonism relate to the degree of renin-angiotensin system blockade in chronic proteinuric kidney diseaseHypertension20095411311919506099
- MannJFGreenDJamersonKfor the ASCEND Study GroupAvosentan for overt diabetic nephropathyJ Am Soc Nephrol20102152753520167702